ClinicalTrials.Veeva

Menu

StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)

University Health Network, Toronto logo

University Health Network, Toronto

Status

Enrolling

Conditions

Cardiac Arrhythmia

Treatments

Radiation: Stereotactic Ablative Radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04843683
20-6027

Details and patient eligibility

About

This is a prospective, single-center, phase II trial that will be monitoring the safety and efficacy of using stereotactic ablative radiotherapy (SBRT) to treat patients with a medical condition affecting heart rate and rhythm (refractory arrhythmias) within the University Health Network (Princess Margaret Cancer Centre and Toronto General Hospital). The primary objective will be to prospectively monitor patient cardiac outcomes following SBRT.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with heart rate and rhythm condition (arrhythmia) who have failed standard of care treatment with medication OR at least one prior invasive catheter ablation procedure.
  • Patients deemed medically fit to receive stereotactic ablative radiotherapy as determined by their Radiation Oncologist.

Exclusion criteria

  • Patients who have previously received high dose radiotherapy to the target area and cannot safely receive further treatment OR are unable to receive radiotherapy due to other contraindications.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Stereotactic ablative radiotherapy (SBRT) Arm
Experimental group
Description:
Stereotactic ablative radiotherapy (SBRT) is a type of radiation treatment that delivers precise, high dose radiation to targeted areas. In this study, a single treatment of SBRT will be delivered to the abnormal area of a participant's heart that is causing dangerous heart rate and rhythm changes (arrhythmia).
Treatment:
Radiation: Stereotactic Ablative Radiotherapy
Observational Arm
No Intervention group
Description:
Potential participants who are eligible to be included in the study, but who choose not to have the SBRT procedure, can still receive standard medical treatment alone and be followed up with study visits and questionnaires.

Trial contacts and locations

1

Loading...

Central trial contact

Benjamin Lok, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems